Takeaki Satoh

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara et al. · Journal of Hepatology · 2012 · 129 citations

Hepatology, Hepatitis C, Viral Hepatitis +12

Short‐term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct‐acting anti‐viral treatment

Eiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura et al. · Alimentary Pharmacology & Therapeutics · 2017 · 111 citations · Full text

Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C

Norihiro Furusyo, Eiichi Ogawa, Makoto Nakamuta et al. · Journal of Hepatology · 2013 · 69 citations

Hepatology, Hepatitis C, Viral Hepatitis +10

Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B

Eiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta et al. · Liver International · 2020 · 59 citations

Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study

Eiichi Ogawa, Makoto Nakamuta, Toshimasa Koyanagi et al. · Alimentary Pharmacology & Therapeutics · 2022 · 52 citations · Full text